Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC, No. 23-1110 (Fed. Cir. Jan. 16, 2024)

Affirmed
Rule 36 Affirmance
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 23-1110
Decided
January 16, 2024
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages
Download Opinion (PDF)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

EAGLE PHARMACEUTICALS, INC.,

Plaintiff-Appellant

v.

SLAYBACK PHARMA LLC, APOTEX INC., APOTEX

CORP.,

Defendants-Appellees

2023-1110

Appeal from the United States District Court for the District of Delaware in No. 1:21-cv-01256-CFC-JLH, Chief Judge Colm F. Connolly.

JUDGMENT

GREGORY G. GARRE, Latham & Watkins LLP, Washington, DC, argued for plaintiff-appellant. Also represented by GABRIEL K. BELL, MICHAEL CLEMENTE; DANIEL BROWN, New York, NY; DAVID KOWALSKI, San Diego, CA. CONSTANCE HUTTNER, Windels Marx Lane & Mittendorf, LLP, Madison, NJ, argued for defendant-appellee Slayback Pharma LLC. Also represented by JASON AARON LIEF.

2ERIC THOMAS WERLINGER, Katten Muchin Rosenman LLP, Washington, DC, argued for defendants-appellees Apotex Inc., Apotex Corp. Also represented by CHRISTOPHER FERENC, TIMOTHY H. GRAY; JOSEPH JANUSZ, JITENDRA MALIK, Charlotte, NC; DEEPRO MUKERJEE, LANCE SODERSTROM, New York, NY.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (LOURIE, PROST, and REYNA, Circuit

Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

Figure on page 2 of the opinion

January 16, 2024

Date

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC, No. 23-1110 (Fed. Cir. Jan. 16, 2024).

Record ID
CAFC-23-1110-20240116
Permalink
https://patentcasewatch.com/opinions/CAFC-23-1110-20240116

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error